BioScrip (BIOS) Reports Q1 EPS of 26c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ANT
4. FFAI
5. FFR
6. LLY
7. TSLA
8. META
9. FICO
10. CART

Go back to BioScrip (BIOS) Reports Q1 EPS of 26c

BioScrip Reports First Quarter 2015 Financial Results

May 7, 2015 5:00 PM EDT

ELMSFORD, N.Y., May 7, 2015 /PRNewswire/ -- BioScrip, Inc. (NASDAQ: BIOS) (the "Company") today announced 2015 first quarter financial results. First quarter revenue from continuing operations was $261.7 million and the net loss from continuing operations was $15.9 million, or $0.26 per diluted share.

First Quarter Highlights

Total revenue increased by $22.4 million, or 9.4%, compared to the prior year period. Revenue from the Infusion Services segment increased to $244.4 million, reflecting 10.6% growth year-over-year, driven by continued strong organic growth; Gross profit from continuing operations was $66.5 million, or 25.4% of revenue, compared to $65.1... More